> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# PMR/PMC Annual Statistical Report
- URL: https://www.fdaweb.com/pmr-pmc-annual-statistical-report/
- Published: 2023-02-02T12:00:00.000Z
- Updated: 2026-09-14T18:14:19.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5153687

The FY 2021 *Report on the Performance of Drugs and Biologics Firms in Conducting Postmarketing Requirements and Commitments* shows that as of 9/30/21 there were 373 unique applicants with open postmarketing requirements (PMR)/postmarketing commitments (PMC) and 808 unique open applications. The [report](https://www.fda.gov/drugs/postmarket-requirements-and-commitments/postmarketing-requirements-and-commitments-reports?utm%5Fmedium=email&utm%5Fsource=govdelivery) also shows that 79% of NDA and BLA annual status reports were received on time.

As of 9/30/21, 69% of open NDA and BLA PMRs were progressing on schedule, as were 76% of NDA and BLA PMCs.

FDA is pleased to report that applicants completed (fulfilled) or released most of the PMRs/PMCs for the previous years reported on in the FY2021 report, the agency says. It says the majority of PMRs/PMCs are progressing according to the original schedule. Overall, very few PMRs/PMCs are delayed, according to FDA.